Iannone, Robert
Cornell University · Columbia University Irving Medical Center · Baylor University Medical Center · Massachusetts General Hospital · Dana-Farber Cancer Institute · Immunomedics (United States) · University of Colorado Cancer Center · Weill Cornell Medicine · Vanderbilt-Ingram Cancer Center
2 papers on CoChat
Most cited papers
- Verified
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Robert, C., Ribas, A., Wolchok, J. D., Hodi, F. S., Hamid, O., Kefford, R., Weber, J. S., Joshua, A. M., Hwu, W.-J., Gangadhar, T. C., et al. (2014) · The Lancet
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 1,774
- Verified
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer
Bardia, A., Mayer, I. A., Vahdat, L. T., Tolaney, S. M., Isakoff, S. J., Diamond, J. R., O’Shaughnessy, J., Moroose, R. L., Santin, A. D., Abramson, V. G., et al. (2019) · New England Journal of Medicine
Breast Cancer Treatment StudiesAdvanced Breast Cancer Therapies
Cited by 874
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free